News & AnalysisAngstrom Bio ropes in $3mAustin-based Angstrom Bio Inc, a developer of molecular diagnostics, has raised $3 million in funding.ByIris Dorbian16 June 2021•3 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs